Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview (2023)
- Authors:
- USP affiliated authors: FERREIRA, LUIS CARLOS DE SOUZA - ICB ; FAVARO, MARIANNA TEIXEIRA DE PINHO - ICB
- Unidade: ICB
- DOI: 10.3390/pharmaceutics15041197
- Subjects: MICROBIOLOGIA; PROTEÍNAS; PROTEÍNAS RECOMBINANTES; MEDICAMENTO; NANOPARTÍCULAS; AMINOÁCIDOS; POLIPEPTÍDEOS; GLICOPROTEÍNAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmaceutics
- ISSN: 1999-4923
- Volume/Número/Paginação/Ano: v. 15, n. 4, art. 1197, p. 1-16, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CORCHERO, José Luis et al. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview. Pharmaceutics, v. 15, n. 4, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15041197. Acesso em: 12 fev. 2026. -
APA
Corchero, J. L., Favaro, M. T. P., Márquez-Martínez, M., Lascorz, J., Martínez-Torró, C., Sánchez, J. M., et al. (2023). Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview. Pharmaceutics, 15( 4), 1-16. doi:10.3390/pharmaceutics15041197 -
NLM
Corchero JL, Favaro MTP, Márquez-Martínez M, Lascorz J, Martínez-Torró C, Sánchez JM, López-Laguna H, Vázquez E, Ferrer-Miralles N, Villaverde A, Parladé E, Ferreira LC de S. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-16.[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/pharmaceutics15041197 -
Vancouver
Corchero JL, Favaro MTP, Márquez-Martínez M, Lascorz J, Martínez-Torró C, Sánchez JM, López-Laguna H, Vázquez E, Ferrer-Miralles N, Villaverde A, Parladé E, Ferreira LC de S. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-16.[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/pharmaceutics15041197 - Evaluation of experimental conditions for quantification of LT produced by human derived enterotoxigenic Escherichia coli strains
- New vaccine approaches against enteropathogenic and enteroheamorrhagic Escherichia coli strains based on intimin expression by recombinant Bacillus subtilis strains
- New vaccine approaches against enteropathogenic and enteroheamorrhagic Escherichia coli strains
- Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules
- Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action
- Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells
- Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors
- Bivalent DNA vaccines confer prophylactic and therapeutic effect on HPV-16 murine tumor
- Expression of a treptococcal M protein epitope fused at different sites of flagellin (FliCd) as an approach for the development of bivalent vaccines based on attenuated Salmonella strains
- Evaluation of the prophylactic and therapeutic effects of anti-cancer DNA vaccine encoding the HPV-16 E7 oncoprotein genetically fused to the HSV-1 GD
Informações sobre o DOI: 10.3390/pharmaceutics15041197 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
